Macrolide Resistance in Streptococcus pyogenes: A Marker of an Overuse of Macrolides

Pediatric Pulmonology

Volumn 44, Issue 12, 2009, Pages 1246-1247

  Korppi, Matti ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN DERIVATIVE; ERYTHROMYCIN; MACROLIDE; PENICILLIN G;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIUM ISOLATE; COMMUNITY ACQUIRED PNEUMONIA; HUMAN; LETTER; PHARYNGITIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SKIN INFECTION; STREPTOCOCCUS PYOGENES;

DRUG RESISTANCE, BACTERIAL; HUMANS; MACROLIDES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TREATMENT OUTCOME;

EID: 73449109191     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21087     Document Type: Letter

References (10)

1. Liu X, Shen X, Chang H, Huang G, Fu Z, Zheng Y, Wang L, Li L, Liu L, Shen Y, et al. High macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China. Pediatr Pulmonol 2009;44:436-441.
2. Fujita K, Murono K, Yoshikawa M, Murai T. Decline of erythromycin resistance of group A streptococci in Japan. Pediatr Infect Dis J 1994;13:1075-1078.
3. Seppälä H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenias H, Lager K, Huouinen P, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 1997;14:337:441-446.
4. Yi YH, Choi JH, Lee HK, Lee KJ, Bae SM, Yu JY, Kim KS. et al. Characterization of erythromycin resistance of Streptococcus pyogenes isolated from pharyngitis patients in Korea. Jpn J Infect Dis 2006;59:192-194.
5. Cizman M. Experiences in prevention and control of antibiotic resistence in slovenia. Euro Surveill 2008;13: pii=19038.
6. Cizman M, Beović B, Seme K, Paragi M, Strumbelj I, Müller-Premru M, Lad-Pecar S, Pokorn M. Macrolide resistance rates in respiratory pathogens in Slovenia following reduced macrolide use. Int J Antimicrob Agents 2006;28:537-53742.
7. Kastrin T, Gubina M, Paragi M, Kolman J, Lizman M, Kraigher A, Ribic H, Sadowy E, Hryniewicz W. Macrolide resistance among invasive Streptococcus pneumoniae in Slovenia. J Antimicrob Chemother 2008;62:628-629.
8. Siira L, Rantala M, Jalava J, Hakanen AJ, Huovinen P, Kaijalainen T, Lyytikäinen O, Virolainen A. Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006. Antimicrob Agents Chemother 2009;53:2066-2073.
9. Korppi M, Heiskanen-Kosma T, Kleemola M. Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serological results of a prospective, population-based study in primary health care. Respirology 2004;9:109-114.
10. Heiskanen-Kosma T, Korppi M, Laurila A, Jokinen C, Kleemola M, Saikku P. Chlamydia pneumoniae is an important cause of community-acquired pneumonia in school-aged children: serological results of a prospective, population-based study. Scand J Infect Dis 1999;31:255-259.